Changing epigenetic markers in CLL patients on ibrutinib
Enhancing autologous cellular therapy with ibrutinib in CLL patients
Iris de Weerdt
Which CLL patients would benefit from intensive therapy?
Pursuing a career in CLL research
Overcoming the shortfalls of ibrutinib with fludarabine in CLL patientss